Santiago to skip Comelec debate to try new anticancer pill

/ 03:39 PM March 17, 2016
Miriam Santiago

Presidential candidate Sen. Miriam Defensor-Santiago during the Presidential Debates 2016 held in Capitol University in Cagayan de Oro City.

Presidential candidate Sen. Miriam Defensor Santiago will not attend the debate hosted by the Commission on Elections in Cebu on Sunday to undergo a clinical trial for a new anticancer pill.

“I am very sorry to miss out on the debates, but it would be a disservice to the country if I forego the opportunity to get rid of my cancer completely and strengthen myself further to serve the Filipino people,” Santiago said in a statement on Thursday.


The senator, who was diagnosed with a stage 4 lung cancer in 2014 but claimed she is in remission, joined an international clinical trial to gain free access to the medication, which would have cost her-half-a-million pesos every three weeks.

The trial will require Santiago to undergo outpatient radiation treatment daily at a hospital for a short period.


The senator said she will try to participate in the next and last presidential debate on April 24 “if the ongoing treatments do not inhibit her.”

Santiago, who is banking on her social media presence and the so-called youth vote, is doing poorly in election surveys. Since the campaign launch last Feb. 9, she only appeared publicly six times.

Her official campus visits in Tacloban and Davao City last week were cancelled “due to logistical concerns.” A planned homecoming in Iloilo with running mate Sen. Ferdinand “Bongbong” Marcos Jr. on Monday was also rescheduled to a later date. TVJ

Read Next
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Cebu debate, Elections 2016, elections featured, Miriam Defensor-Santiago, presidential debates
For feedback, complaints, or inquiries, contact us.

© Copyright 1997-2019 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.